Glucophage Tablet: A Consumer Guide to Uses, Side Effects, and Price - in the UK

Summary of the material

Medicine name: Glucophage (commonly referred to by the active ingredient metformin).

The active component is metformin.

Therapeutic class: biguanide oral antihyperglycaemic agent.

Primary purpose: a first-line medicine for adults with type 2 diabetes, used together with diet and exercise to reduce high blood glucose.

This page provides practical guidance on administration (how to take a screenshot), typical doses (strengths and dosing), kidney-related adjustments (renal dosing protocol guidance), and routes to obtain the medicine legally in the UK (The legal position in the UK and access).

Metformin's action in the body and common tokens

Metformin lowers blood sugar without directly stimulating insulin secretion. Its main effects include the following:

• Reducing glucose production by the liver.
• Improving insulin sensitivity in peripheral tissues to increase glucose uptake.
• Lowering absorption of dietary glucose from the gut.

Because metformin does not promote insulin release from the pancreas, the risk of low blood sugar when taken alone is small, and many people experience no weight gain; some report slight weight loss.

Licensed use in the UK: management of type 2 diabetes in adults when lifestyle measures alone are insufficient. In practice, metformin may be used on its own or in combination with other glucose lowering therapies; specialist clinics may use it for additional indications under clinical judgement. Examine the administrative details how to take exams.

How to take up a hobby Glucophage

• Only take metformin if it has been prescribed for you; do not share medication with others.
• Take tablets with food to reduce stomach upset; immediate-release doses are often taken with breakfast and evening meals.
• Do not crush, split, or chew modified-release tablets; swallow them whole with water.
• Your clinician will usually start at a low dose and increase gradually to reduce gastrointestinal unwanted effects.
• If your regimen changes or you develop new symptoms, contact your GP or pharmacist for advice.

If you forget your doseevaluation the guidance at guidance for skipping a dose. Inspect the in computing, storage means the capacity to retain data over time. information safe a storage solution should balance access and protection. guidance.

Which strengths are available and usual dosing patterns

Typical tablet strengths available in the UK include 500 mg, 850 mg, 1000 mg and less commonly 250 mg. Metformin is supplied both as immediate-release and modified-release formulations.

Immediate-release dosing commonly starts at 500 mg once daily or 500 mg twice daily with meals, or 850 mg once daily, then increased every 1 to 2 weeks as tolerated. Many regimens use divided doses; upper daily limits depend on product labeling and clinical judgement, often up to about 2000-2550 mg daily.

Modified-release (MR) tablets are frequently taken once daily with the evening meal; some brands permit twice-daily administration. MR preparations must not be split or crushed. Choose a dose that matches kidney function and tolerability; see kidney-related dosing guidelines and monitoring in real time for follow up.

Kidney function and dose adjustments

Metformin is eliminated by the kidneys. The following are commonly used thresholds based on estimated glomerular filtration rate (eGFR):

• eGFR 60 mL/min/1.73 m2 or higher: standard dosing with at least annual renal review.
• eGFR 45 to 59 mL/min/1.73 m2: consider reducing dose and monitor renal function every 3 to 6 months.
• eGFR 30 to 44 mL/min/1.73 m2: do not start metformin; if already taking itreexamination the need and consider limiting to 500-1000 mg daily with close performance monitoring.
• eGFR below 30 mL/min/1.73 m2: metformin is contraindicated; discontinue and use standby representatives.

Temporary interruption may be advised around procedures using iodinated contrast media or during acute illness that could impair kidney function. Restart metformin only when renal function is stable and you have clinician approval. See related warning notices at standard precautions along with these notice of risk are important.

Vigilant keeping track of metrics and follow-up checks

• HbA1c: typically measured every 3 months until control stabilises, then every 6 months.
• Renal function (creatinine/eGFR): baseline and at least yearly; more frequent checks if eGFR is below 60 or clinical status changes.
• Vitamin B12: consider periodic testing for long-term users or if there are symptoms of neuropathy or anaemia.
• Weight and blood pressure: reviewed during routine diabetes checks.

Individual real time monitoring of systems schedules should be personalised by your diabetes team. If glycaemic targets are not achieved, discuss other options under other choices and also their prices. and verify adherence at how to take charge.

Safety critical protective steps and alerts

Lactic acidosis is a rare but serious adverse event associated with metformin accumulation. If you experience severe symptoms, seek urgent medical attention without delay. any of the following together:

• Rapid or shallow breathing or shortness of breath
• Severe tiredness, dizziness, or unexpected weakness
• Abdominal or muscle pain, or fainting
• Feeling very cold or an irregular heartbeat

Hypoglycaemia is uncommon with metformin alone but the risk increases when it is combined with insulin or sulfonylureas. If you take such combinations, be prepared to treat low blood glucose and carry a quick source of carbohydrate.

Avoid heavy alcohol use because it increases the risk of lactic acidosis and may destabilise blood glucose. Inform healthcare teams before imaging with iodinated contrast or planned surgery; temporary suspension of metformin may be required. During acute illness with dehydration, vomiting, or reduced oral intake, your clinician may advise a pause in treatment until you recover.

Long-term metformin use can be associated with lower vitamin B12 levels; discuss testing if you develop symptoms such as numbness or anaemia. For renal guidance see kidney-related dosing guidelines.

Who should not take metformin

• eGFR less than 30 mL/min/1.73 m2 or acute severe renal impairment
• Known hypersensitivity to metformin or any of the tablet ingredients
• Conditions associated with tissue hypoxia, for example decompensated heart failure or severe respiratory failure
• Uncontrolled metabolic acidosis, diabetic ketoacidosis, or hyperglycaemic coma
• Grave hepatic disease
• Severe infection, dehydration, or shock which increase lactic acidosis risk
• Liquor dependence or heavy alcohol use
• Very low calorie diets in which intake is typically under 1000 kcal per day
• Past history of lactic acidosis
• Peri-procedural periods involving iodinated contrast until kidney function is confirmed stable
• Use during pregnancy or breastfeeding only after specialist discussion of risks and benefits

Older adults with multiple medical problems should have an individualised risk-benefit review before starting or continuing metformin. Contact a healthcare professional if any of these apply to you.

Short term effects that are common and less common

The most frequent unfavorable health effects are gastrointestinal and tend to occur when treatment starts or when the dose is increased. Taking metformin with food and titrating slowly usually reduces these problems.

• Diarrhoeal illness, bloating, or excess gas
• Nausea, vomiting, and abdominal discomfort
• Appetite is down or an altered metallic taste
• Weight is typically stable or may fall slightly; report unexpected weight changes

Less typical effects include skin rash or hives; very rarely angioedema can occur. Seek urgent help for swelling of the face, lips, tongue, or difficulty breathing. Signs suggesting lactic acidosis are listed in safety notices and precautionary advisories and require emergency attention.

Consider vitamin B12 assessment if you develop neuropathic symptoms or unexplained anaemia during long-term therapy.

Conversational clear interpersonal dialogue and exchanges reduce confusion. with over-the-counter medicines and substances

Always tell prescribers and pharmacists about all medicines, over-the-counter treatments and herbal products you use. Examples of relevant the study maps how intercommunications evolve over time. include:

• Medicines that may reduce glucose lowering: corticosteroids, some thyroid hormones, thiazide diuretics, and certain hormonal therapies.
• Medicines that can increase hypoglycaemia risk when combined with metformin: insulin and sulfonylureas.
• Drugs that may raise metformin concentrations: cimetidine; status monitoring or dose review may be required.
• Loop diuretics and some other diuretics: can affect renal handling and require metric monitoring.
• Carbonic anhydrase inhibitors such as topiramate may increase acidosis risk and should be used with caution.
• Alcohol bottle increases lactic acidosis potential and can destabilise glucose control.

Before scans involving iodinated contrasttake a moment to verify. guidance in risk awareness, careful precautions, and cautions issued and with the radiology team regarding temporary interruption.

Advice regarding a failure to take a dose

• If you remember soon after the scheduled time, take the missed tablet with food.
• If the next dose is close, skip the dose was skipped and continue with your normal schedule; do not double up doses.
• If you miss doses frequently, ask your pharmacist about reminder aids or whether a modified-release option is suitable.

See overdose on medicine awareness information for guidance on accidental excessive intake.

Overdose syndrome and emergency management measures

Exceeding the prescribed dose can cause severe stomach upset and, with large overdose incidents, lactic acidosis. Features of lactic acidosis include rapid or deep breathing, extreme tiredness, cold skin, slow heartbeat, and fainting. Call emergency services or head on to the nearest emergency department without delay.

Metformin itself does not commonly cause low blood sugar, but combinations with other antidiabetic drugs can. If you feel symptoms of hypoglycaemia such as shaking, sweating, confusion or severe hungerverify this. your glucose and treat with fast-acting carbohydrate as advised by your healthcare team.

Methods for bulk storage space is needed to store more belongings. and disposal

• Store at room temperature, ideally between 20 and 25 degrees C.
• Keep away from heat, moisture and direct sunlight; do not store in bathrooms.
• Do not allow access by children or pets.
• Do not use beyond the expiry date printed on the pack; return unused or expired medicines to a pharmacy for safe disposal.
• With modified-release tablets you may sometimes see an intact outer shell in stool; the medicine has already been released.

Nonmainstream therapies and indicative UK consumer prices

The choice of therapy is individual and depends on factors such as kidney function, cardiovascular risk, weight objectives, cost and side effect profile. Prices quoted are approximate private retail costs in GBP and may vary by region, pharmacy and pack size. NHS prescription rules apply as described under UK legal standing and availability.

Metformin options and approximate costs

• Generic metformin immediate-release (500 mg): around 1 to 5 GBP for a 28 to 56 tablet supply.
• Metformin modified-release (MR): commonly 6 to 15 GBP per month privately, depending on brand.
• Fixed-dose combinations with metformin (for example with a DPP-4 inhibitor): commonly 20 to 55 GBP per month depending on agent and strength.

Other glucose lowering classes and indicative private costs

• SGLT2 inhibitors (empagliflozin, dapagliflozin): about 20 to 45 GBP per month; selected for cardiorenal benefit in appropriate patients.
• DPP-4 inhibitors (sitagliptin, linagliptin): about 20 to 40 GBP per month.
• Sulfonylureas (gliclazide, glimepiride): low-cost generics, around 2 to 6 GBP per month; higher hypoglycaemia risk.
• GLP-1 receptor agonists (semaglutide, dulaglutide): injectable or oral; often 70 to 150+ GBP per month privately and may support weight loss.
• Pioglitazone (thiazolidinedione): generic and inexpensive, roughly 1 to 4 GBP per month but avoided in some conditions such as heart failure.
• Insulin preparations: costs vary widely by type and dose; require individualised titration and supply arrangements.

Discuss options with your prescriber to match treatment to your medical profile, kidney status and personal goals. Notice the official documentation on legal supply routes. Status under British access to law and legal remedies and for how to take pills the medicine see how to take.

UK legal classification and ways to obtain metformin

• Legal classification: Prescription Only Medicine (POM) in the UK.
• Supply routes: issued on an NHS prescription or a private prescription from a prescriber registered in the UK and dispensed by a pharmacy registered with the General Pharmaceutical Council (GPhC).
• Online services: use only GPhC-registered pharmacies and prescribers regulated by the Care Quality Commission (CQC). A legitimate clinical assessment and a UK prescription are required for supply.
• Emergency supply: a community pharmacist may provide a short emergency supply in limited circumstances after assessment; this is not a substitute for regular prescribing.
• Importing medicines: personal importation of prescription-only medicines is restricted; using UK-registered suppliers ensures product quality and legal compliance.
• NHS prescription charges: most adults in England pay a fixed charge per item; prescriptions are free in Scotland, Wales and Northern Ireland. Exemptions and prepayment certificates exist.
• Records: keep dispensing labels and receipts; many NHS practices use the Electronic Prescription Service (EPS).
• Driving: metformin on its own carries minimal hypoglycaemia risk. If you use it with agents that can cause lows, follow DVLA and clinical guidance on fitness to drive.

To check a pharmacy or prescriber, search the GPhC register. For safety alerts consult MHRA resources. For dosing details, refer back to the product label. strong suits and dosing.

Commonly asked questions

How quickly does metformin start to work?

Some changes in blood glucose can occur within days, but HbA1c reflects average control over approximately three months. Slow dose increases help minimise stomach upset; see how to take a screenshot.

Will metformin cause weight loss?

Metformin is usually weight neutral or associated with modest weight loss. If weight loss is a primary goal, discuss options such as SGLT2 inhibitors or GLP-1 receptor agonists under option other options and pricing overview details..

Will alcohol affect metformin when I am taking it?

Keep your alcohol consumption moderate. Heavy drinking increases the risk of lactic acidosis and can interfere with glucose control. See required precautions with corresponding alerts.

Is metformin safe for pregnant individuals?

Use in pregnancy should only be on specialist advice. Treatment of diabetes in pregnancy is personalised and closely monitored.

Am I able to split or crush the tablets?

Do not split, crush or chew modified-release tablets. Follow product instructions and prescriber advice.

What should I do before a CT scan with contrast?

Inform the imaging team that you take metformin. Temporary suspension may be advised before and after iodinated contrast until kidney function is confirmed stable. See kidney function dosing guidelines and protective guidelines and warning notices.